235 related articles for article (PubMed ID: 10604133)
1. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours.
Dominguez S; Denys A; Menu Y; Ruszniewski P
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S213-5. PubMed ID: 10604133
[TBL] [Abstract][Full Text] [Related]
2. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
3. [Influence factors in hepatic artery infusion chemotherapy and embolization of liver metastases from alimentary tract cancer].
Li H; Zeng H; Yang L
Zhonghua Gan Zang Bing Za Zhi; 1999 Sep; 7(3):142-3. PubMed ID: 10572679
[TBL] [Abstract][Full Text] [Related]
4. [The clinical efficacy of hepatic artery infusion chemotherapy and chemoembolization in the treatment of liver metastases].
Zeng X; Wang S; Wei C
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):365-7. PubMed ID: 9387277
[TBL] [Abstract][Full Text] [Related]
5. Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.
Skinazi F; Zins M; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):673-8. PubMed ID: 8853257
[TBL] [Abstract][Full Text] [Related]
6. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.
Christante D; Pommier S; Givi B; Pommier R
Surgery; 2008 Dec; 144(6):885-93; discussion 893-4. PubMed ID: 19040993
[TBL] [Abstract][Full Text] [Related]
7. [Liver metastases from breast cancer--clinical features and treatment].
Masuda N; Yayoi E; Nakano Y; Monden T; Okamura J
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1406-11. PubMed ID: 9703840
[TBL] [Abstract][Full Text] [Related]
8. [Infusion chemotherapy and chemoembolization of liver metastases from cancer of the alimentary tract].
Zeng H; Li H; Shi Z
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):422-4. PubMed ID: 11778283
[TBL] [Abstract][Full Text] [Related]
9. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
10. [Hepatic arterial infusion chemotherapy and embolization in the treatment of hepatic carcinoma].
Wang ZY; Shi ZH; Zai RY
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):454-7. PubMed ID: 7720505
[TBL] [Abstract][Full Text] [Related]
11. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi W; Chatzissavvidis I; Valek V
Eur J Surg Oncol; 2001 Nov; 27(7):652-61. PubMed ID: 11669594
[TBL] [Abstract][Full Text] [Related]
13. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA
Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136
[TBL] [Abstract][Full Text] [Related]
14. Systemic chemotherapy of advanced digestive neuroendocrine tumours.
Rougier P; Ducreux M
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S202-6. PubMed ID: 10604131
[TBL] [Abstract][Full Text] [Related]
15. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours.
O'Toole D; Ruszniewski P
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):585-94. PubMed ID: 16183529
[TBL] [Abstract][Full Text] [Related]
16. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours.
Dominguez S; Denys A; Madeira I; Hammel P; Vilgrain V; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):151-7. PubMed ID: 10741928
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous hepatic arterial chemotherapy and chemoembolization.
Lynes AC
Cancer Nurs; 1993 Aug; 16(4):283-7. PubMed ID: 8402604
[TBL] [Abstract][Full Text] [Related]
20. [Transcatheter treatment of hepatic metastasis from stomach cancer].
Tarazov PG; Granov DA; Polikarpov AA
Vopr Onkol; 2000; 46(2):220-3. PubMed ID: 10853427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]